Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
B7-H3.CD28Z.CART in CNS Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
B7-H3.CD28Z.CART in Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE3
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Status
- RECRUITING
- Phase
- PHASE1
BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3